The term emerging disease refers to infections or diseases that are new to a geographical location or are already known but occur in excess of their expected frequencies. We often discuss tropical diseases in this context. These typically occur in the tropical regions but can also occur elsewhere say due to transmission by returning travelers. Under the umbrella of emerging diseases, we talk about:
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
wdt_ID | Method | Parameter | Substrate | Species/ Antigen |
---|---|---|---|---|
708 | IFA | MERS-CoV, SARS-CoV negative control |
||
709 | IFA | SARS coronavirus | infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 |
710 | IFA | MERS coronavirus | infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 |
711 | ELISA | MERS coronavirus | antigen-coated microplate wells |
recombinant S1 antigen of MERS coronavirus (MERS-CoV S1) |
712 | ELISA | SARS-CoV-2 | antigen-coated microplate wells |
recombinant S1 antigen of SARS-CoV-2 |
713 | PCR | EURORealTime SARS-CoV-2 | ||
714 | ELISA | SARS-CoV-2 NCP | ||
715 | IFA | antibodies against TBE virus (TBEV) IgG positive control |
||
716 | IFA | antibodies against TBE virus (TBEV) IgM positive control |
||
717 | IFA | TBE virus (TBEV) | infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 |
718 | IFA | TBE virus (TBEV) negative control |
||
719 | ELISA | TBE virus | antigen-coated microplate wells |
TBE viral proteins (strain "K23") |
720 | ELISA | TBE virus incl. IgG/RF absorbent |
antigen-coated microplate wells |
TBE viral proteins (strain "K23") |
721 | IFA | antibodies against Flaviviruses IgG positive control |
||
722 | IFA | Flavivirus Mosaic 1 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 |
723 | IFA | Flaviviruses negative control |
||
724 | ELISA | TBE virus avidity determination |
antigen-coated microplate wells |
TBE viral proteins (strain "K23") |
725 | IFA | Flavivirus Profile 2 upper row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) bottom row: Dengue virus types 1 - 4 (DENV) |
infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 |
726 | IFA | Flavivirus Mosaic 3 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) Dengue virus types 1 - 4 (DENV) |
9 BIOCHIPs per field: infected cells infected cells infected cells infected cells infected cells non-infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 EU 14 |
727 | ELISA | CSQ pair of controls anti-TBE virus Vienna (IgG) |
||
728 | ELISA | TBE virus Vienna |
antigen-coated microplate wells |
TBE viral proteins (strain "K23") |
729 | ELISA | CSQ pair of controls anti-TBE virus (IgG) |
||
730 | ELISA | CSQ pair of controls anti-TBE virus (IgM) |
||
731 | ELISA | TBE virus antibody determination in CSF |
antigen-coated microplate wells |
TBE viral proteins (strain "K23") |
732 | IFA | antibodies against West Nile virus (WNV) IgG positive control |
2023 EUROIMMUN US